article thumbnail

The Imperative for KAM in Pharma

PM360

Over the past decade, macro trends in healthcare have pushed life sciences companies to pursue increasingly sophisticated key account management (KAM) strategies and capabilities to provide unique offerings and value. This leads to fewer health systems treating a larger percentage of total patients each year.

article thumbnail

The 2024 PM360 Pharma Choice Awards – Unbranded Bronze Winner

PM360

The customer also stressed the importance of understanding the unique characteristics of the condition in patients with skin of color.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Largest global clinical site hires all-female key leaders in Europe

European Pharmaceutical Review

She has 20 years’ experience in business development and key account management in the clinical trials arena. About Velocity Clinical Research Velocity Clinical Research helps biopharmaceutical and CRO customers find the right patients for their studies.

article thumbnail

Gaining Market Access in Emerging Markets – Take Action!

Clarity Engagement Solutions

The goal is to create a collaborative relationship with stakeholders based around the development of the value propositions that address the needs of policy makers, patients and payers. A survey conducted by Cegedim revealed that Key Account Management (KAM) was the technique that procured the best results for market access strategies.

article thumbnail

Gaining Market Access in Emerging Markets – Take Action!

Clarity Engagement Solutions

The goal is to create a collaborative relationship with stakeholders based around the development of the value propositions that address the needs of policy makers, patients and payers. A survey conducted by Cegedim revealed that Key Account Management (KAM) was the technique that procured the best results for market access strategies.

article thumbnail

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Asaf Evenhaim, CEO, Crossix, explains that “connecting HCPs and patients to essential and timely education has long been the aim of pharma marketers.

Marketing 105
article thumbnail

Adapting Customer Engagement Strategies to the COVID Landscape

Pharma Marketing Network

Everything from training field personnel to navigate new tools more efficiently from remote environments, to changing both the offering and its customer platform (HCPs and patients) to create the highest level of value and impact will need renewed strategic attention. Leading Teams in the “New Normal” Environment.